Medical Textiles Market Facts at a Glance- Total Pages: 120 Companies: 10+ – Including Ahlstrom-Munksjo Oyj, Asahi Kasei…
Category: Insights
The Flow Diversion Aneurysm Market size to grow by USD 1.75 billion | Market Research Insights highlight The increasing prevalence of IAs and associated risk factors as Key Driver
According to the research report “Flow Diversion Aneurysm Treatment Market by Product and Geography – Forecast…
Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines
Nuance Pharma (“Nuance”or the “Company”), a specialty care focused biopharma with late late-stage clinical programs and…
Interstitial Cystitis Drugs Market Size to grow by USD 283.95 million | Market Insights highlight the high prevalence of interstitial cystitis as key driver
According to the research report “Interstitial Cystitis Drugs Market by Type and Geography – Forecast and…
Sameday Health Hiring 1,000 Nurses To Support Country-Wide Clinic Expansion & Launch of House Calls Service
Sameday Health, a leading COVID testing organization and premium healthcare provider, is expanding its medical operations…
Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…
Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere’s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema
Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the…
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) announced today that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and…
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Immunic, Inc. (Nasdaq: IMUX),a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating…
PHBI – Phramagreen Targets Making Its Chibafreen Propriety Technology A Cannabis Industry Standard
Pharmagreen Biotech, Inc., (OTC PINKS: PHBI), today released a second management update form CEO Peter Wojcik. Today’s…